George S Mack

749 total citations
32 papers, 530 citations indexed

About

George S Mack is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology and Reproductive Medicine. According to data from OpenAlex, George S Mack has authored 32 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Public Health, Environmental and Occupational Health, 7 papers in Molecular Biology and 6 papers in Reproductive Medicine. Recurrent topics in George S Mack's work include Biotechnology and Related Fields (6 papers), Science, Research, and Medicine (6 papers) and Biomedical Ethics and Regulation (5 papers). George S Mack is often cited by papers focused on Biotechnology and Related Fields (6 papers), Science, Research, and Medicine (6 papers) and Biomedical Ethics and Regulation (5 papers). George S Mack collaborates with scholars based in United States. George S Mack's co-authors include Andrew Marshall and has published in prestigious journals such as Nature Medicine, Nature Biotechnology and JNCI Journal of the National Cancer Institute.

In The Last Decade

George S Mack

24 papers receiving 500 citations

Peers

George S Mack

MB

CR

ONCOL

PRM

GENET

Danièle Salaün France

Masayuki Okada Japan

Barbara Lamb United States

Kim Clarke United Kingdom

Catherine Lee United States

Marie-Christine Multon France

Magid Fallahi United States

Igor Katsyv United States

Carmine T. Lago Italy

Clare Dempsey United Kingdom

Danièle Salaün France

George S Mack

329 ×1.0

MB

54 ×0.5

CR

95 ×1.6

ONCOL

33 ×0.6

PRM

42 ×0.8

GENET

Citations per year, relative to George S Mack George S Mack (= 1×) peers Danièle Salaün

Countries citing papers authored by George S Mack

Since Specialization

Citations

This map shows the geographic impact of George S Mack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George S Mack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George S Mack more than expected).

Fields of papers citing papers by George S Mack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George S Mack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George S Mack. The network helps show where George S Mack may publish in the future.

Co-authorship network of co-authors of George S Mack

This figure shows the co-authorship network connecting the top 25 collaborators of George S Mack. A scholar is included among the top collaborators of George S Mack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George S Mack. George S Mack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Mack, George S, et al.. (2013). Goodbye, post-acute care. 'Heavy-lifting' will shift to community-based care.. PubMed. 43(3). 26–26. 1 indexed citations

2.

Mack, George S, et al.. (2013). Evaluating the Palliative Care Workforce in Southern California: A Conversation. Journal of Palliative Medicine. 16(9). 1115–1117. 1 indexed citations

3.

Mack, George S & Andrew Marshall. (2010). Lost in migration. Nature Biotechnology. 28(3). 214–229. 61 indexed citations

4.

Mack, George S. (2009). FDA holds court on post hoc data linking KRAS status to drug response. Nature Biotechnology. 27(2). 110–112. 15 indexed citations

5.

Mack, George S. (2009). Mixed news for Avastin. Nature Biotechnology. 27(6). 494–494.

6.

Mack, George S. (2008). CD20 blockers eye crowded rheumatology market. Nature Biotechnology. 26(10). 1053–1054. 3 indexed citations

7.

Mack, George S. (2008). FDA balks at Myozyme scale-up. Nature Biotechnology. 26(6). 592–592. 10 indexed citations

8.

Mack, George S. (2007). MicroRNA gets down to business. Nature Biotechnology. 25(6). 631–638. 109 indexed citations

9.

Mack, George S. (2007). Pfizer dumps Exubera. Nature Biotechnology. 25(12). 1331–1332. 45 indexed citations

10.

Mack, George S. (2006). Ariad Pharmaceuticals Wins First Round Over Eli Lilly, Patents on Methods Can Be Far-reaching. JNCI Journal of the National Cancer Institute. 98(15). 1028–1030. 2 indexed citations

11.

Mack, George S. (2006). Epigenetic Cancer Therapy Makes Headway. JNCI Journal of the National Cancer Institute. 98(20). 1443–1444. 74 indexed citations

12.

Mack, George S. (2006). Clinical Trials Going to the Dogs: Canine Program To Study Tumor Treatment, Biology. JNCI Journal of the National Cancer Institute. 98(3). 161–162. 15 indexed citations

13.

Mack, George S. (2005). Momentous patent case may not be resolved anytime soon.

14.

Mack, George S. (2005). Cancer researchers usher in dog days of medicine. Nature Medicine. 11(10). 1018–1018. 22 indexed citations

15.

Mack, George S. (2005). Overreaction to violations stifle innovation.

16.

Mack, George S. (2005). Early-stage exits: sometimes, less is more. PubMed. 23(7). 779–779. 2 indexed citations

17.

Mack, George S. (2005). Canada's alternative biotech scene is an island apart. 1 indexed citations

18.

Mack, George S. (2004). Can complexity be commercialized?. Nature Biotechnology. 22(10). 1223–1229. 19 indexed citations

19.

Mack, George S. (1961). Mammals from south-western Queensland. Biodiversity Heritage Library (Smithsonian Institution). 9 indexed citations

20.

Mack, George S. (1953). Nouvelles présentations au Queensland Museum, Brisbane. Museum International (Edition Francaise). 6(3). 178–183. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact